Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregnenolone to Target Concurrent Posttraumatic Stress Disorder (PTSD) and Stress Induced Alcohol Use in Veterans: A Dose Finding Study

NCT06580444 is registered in ClinicalTrials.gov with Pharmacotherapies for Alcohol and Substance Use Disorders Alliance as lead sponsor.

NCT NCT06580444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06580444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregnenolone to Target Concurrent Posttraumatic Stress Disorder (PTSD) and Stress Induced Alcohol Use in Veterans: A Dose Finding Study
Lead sponsor
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 15, 2027
Completion date
December 31, 2027
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud), post traumatic stress disorder (ptsd)